These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32622622)

  • 1. Comparison of safety between high and low doses of sulbactam/ampicillin: A retrospective observational study in Japanese patients with pneumonia.
    Imanishi K; Nakakura I; Miyabe T; Sako R; Yamauchi K
    J Infect Chemother; 2020 Nov; 26(11):1152-1157. PubMed ID: 32622622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk evaluation of ampicillin/sulbactam-induced liver injury based on albumin-bilirubin score.
    Ooi H; Asai Y; Sato Y
    J Infect Chemother; 2023 Sep; 29(9):900-904. PubMed ID: 37301371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study.
    Suzuki T; Sugiyama E; Nozawa K; Tajima M; Takahashi K; Yoshii M; Suzuki H; Sato VH; Sato H
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00746. PubMed ID: 33764686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower Body Mass Index is a Risk Factor for In-Hospital Mortality of Elderly Japanese Patients Treated with Ampicillin/sulbactam.
    Miura M; Kuwahara A; Tomozawa A; Omae N; Yamamori M; Kadoyama K; Sakaeda T
    Int J Med Sci; 2016; 13(10):749-753. PubMed ID: 27766023
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
    Ishibashi T; Harada Y; Takamoto M; Ebihara M; Sugiyama M; Shimazu K; Iwanaga T; Kishikawa R; Makie T; Tsurutani H; Kisanuki K; Mitsuno T; Hirota N; Furuno T; Hiraoka T; Tsumori Y; Matsuura Y; Namba K; Oe T; Inuyama M; Chifu S; Fukunaga H; Ueno Y; Matsukizono K; Genka K
    Jpn J Antibiot; 1998 Dec; 51(12):746-58. PubMed ID: 10077773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
    Kohno S; Yanagihara K; Yamamoto Y; Tokimatsu I; Hiramatsu K; Higa F; Tateyama M; Fujita J; Kadota J
    J Infect Chemother; 2013 Dec; 19(6):1035-41. PubMed ID: 23695232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial.
    Hamao N; Ito I; Konishi S; Tanabe N; Shirata M; Oi I; Tsukino M; Matsumoto H; Yasutomo Y; Kadowaki S; Hirai T
    BMC Pulm Med; 2020 Jun; 20(1):160. PubMed ID: 32503515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
    Kohno S; Tateda K; Mikamo H; Kadota J; Niki Y; Itamura R
    J Infect Chemother; 2015 Mar; 21(3):182-8. PubMed ID: 25533886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone versus ampicillin/sulbactam for the treatment of aspiration-associated pneumonia in adults.
    Hasegawa S; Shiraishi A; Yaegashi M; Hosokawa N; Morimoto K; Mori T
    J Comp Eff Res; 2019 Nov; 8(15):1275-1284. PubMed ID: 31736321
    [No Abstract]   [Full Text] [Related]  

  • 10. Ampicillin/sulbactam versus cefazolin plus aminoglycosides for antimicrobial prophylaxis in management of Gustilo type IIIA open fractures: A retrospective cohort study.
    Takahara S; Tokura T; Nishida R; Uefuji A; Ichimura K; Nishihara H; Aoki K; Takayama H; Nakagawa N; Harada T
    Injury; 2022 Apr; 53(4):1517-1522. PubMed ID: 35090733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
    Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
    Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sulbactam/ampicillin-induced pneumonitis].
    Miyashita N; Nakajima M; Kuroki M; Kawabata S; Hashiguchi K; Niki Y; Kawane H; Matsushima T
    Nihon Kokyuki Gakkai Zasshi; 1998 Aug; 36(8):684-9. PubMed ID: 9844387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory and clinical studies of sulbactam/ampicillin in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Sugita K; Takagi M
    Jpn J Antibiot; 1989 Mar; 42(3):687-700. PubMed ID: 2746849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic and clinical studies of sultamicillin granule in the pediatric field].
    Motohiro T; Sakata Y; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Yamashita F; Takajo N
    Jpn J Antibiot; 1988 Dec; 41(12):1980-2000. PubMed ID: 3249372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ampicillin- and ampicillin/sulbactam-resistant Escherichia coli infection in a neonatal intensive care unit in Japan.
    Saida K; Ito Y; Shima Y; Kasuga E; Kusakari M; Miyosawa Y; Baba A
    Pediatr Int; 2016 Jun; 58(6):537-9. PubMed ID: 27322865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on sulbactam/ampicillin in the field of pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebrospinal fluid levels of sulbactam/ampicillin in rabbits with staphylococcal meningitis].
    Haruta T; Okura K; Kuroki S; Yamamoto H; Kobayashi Y
    Jpn J Antibiot; 1989 Mar; 42(3):594-7. PubMed ID: 2746844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in children].
    Hattori K; Higashino H; Kobayashi T; Yamamoto C; Nobori U; Nakamura Y; Satou Y; Kurokawa H; Nogi S; Kobayashi Y
    Jpn J Antibiot; 1989 Mar; 42(3):701-17. PubMed ID: 2746850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pharmacokinetic studies on intravenous administration of sulbactam/ampicillin in pediatrics].
    Sato H; Narita A; Suzuki H; Nakazawa S; Matsumoto K; Nakanishi Y; Niino K; Nakazawa S
    Jpn J Antibiot; 1989 Mar; 42(3):623-38. PubMed ID: 2746846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of sulbactam/ampicillin in children].
    Ito S; Mayumi M; Ito M; Mikawa H
    Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.